GlaxoSmithKline Plc
Last updated on 2017-03-21T20:07+0300.
About this image
| Key Titles and Phrases | Count | Lang | Last Seen |
|---|
| Names | Lang | Count |
|---|---|---|
| Glaxosmithkline Plc | EN | 100.00% |
| Type | Entity Name | Count |
|---|---|---|
 | GlaxoSmithKline | 8.62% |
| Inc | 6.74% |
| Pfizer Inc | 3.96% |
| Novartis | 2.18% |
 | Donald Trump | 2.18% |
| Pharmaceuticals Inc | 1.68% |
| SA | 1.49% |
| Reuters Group | 1.39% |
| Anthony Fauci | 1.39% |
| World Health Organization | 1.29% |
| Eli Lilly | 1.09% |
| Roche Holding AG | 1.09% |
| British | 1.09% |
| Mike | 0.99% |
| Mike Pence | 0.99% |
| AstraZeneca PLC | 0.99% |
| Association | 0.89% |
| Commission | 0.89% |
| Abbott Laboratories | 0.79% |
| Bristol Myers Squibb | 0.79% |
| Andrew Cuomo | 0.79% |
| Drug Administration | 0.79% |
| Takeda Pharmaceutical | 0.69% |
| Boris Johnson | 0.69% |
| Bloomberg News | 0.69% |
| Roche Ltd | 0.59% |
| Centers for Disease Control and Prevention | 0.59% |
| National Health | 0.59% |
| Teva Pharmaceuticals | 0.59% |
| Saudi | 0.59% |
| Type | Entity Name | Score |
|---|---|---|
| GlaxoSmithKline | 0.0723 |
| Pfizer Inc | 0.0382 |
| Novartis | 0.0202 |
| Inc | 0.0158 |
| Pharmaceuticals Inc | 0.0158 |
| Roche Holding AG | 0.011 |
| Eli Lilly | 0.0104 |
| AstraZeneca PLC | 0.0087 |
| Bristol Myers Squibb | 0.0079 |
| SA | 0.0074 |
| Abbott Laboratories | 0.0074 |
| Takeda Pharmaceutical | 0.0072 |
| Nitin Paranjpe | 0.0065 |
| Teva Pharmaceuticals | 0.0063 |
| Roche Ltd | 0.006 |
| Mikael Dolsten | 0.0056 |
| Anthony Fauci | 0.0054 |
| Bloomberg News | 0.0054 |
| Becton Dickinson | 0.0053 |
| Renal Care | 0.0051 |
| Michael Erman | 0.005 |
| Takeda Pharmaceutical Co | 0.005 |
| Laboratories Ltd | 0.005 |
| Dr Reddy | 0.0049 |
| OECD | 0.0048 |
| Laura Wood | 0.0048 |
| CSL Ltd | 0.0048 |
| Facebook Inc | 0.0044 |
| Daiichi Sankyo | 0.0042 |
| Rick Bright | 0.0042 |
Show/hide duplicate news articles.
Show/hide duplicate news articles.
Tools
Sunday, April 5, 2020
3:54:00 AM EAT
Languages 
Select your languages
Explore Relations
Please send any comments or suggestions to 